Your session is about to expire
← Back to Search
IDegLira for Type 2 Diabetes(REMITiDegLira Trial)
REMITiDegLira Trial Summary
This trial will compare the effects of two different diabetes treatment approaches in people with early type 2 diabetes.
- Type 2 Diabetes
REMITiDegLira Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
REMITiDegLira Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2022 Phase 3 trial • 145 Patients • NCT03737240
Awards & Highlights
REMITiDegLira Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
For this particular test, are elderly citizens able to participate?
"People aged 30 to 80 who meet the other specified inclusion criteria can apply for this trial. In contrast, there are 227 clinical trials specifically for people under 18 and 1330 research studies for patients over 65."
Could you please list any other research studies that have included IDegLira?
"IDegLira was first trialled in America, at George Washington University, back in 2002. Since then, a total of 1467 clinical trials have completed. At the moment, there are 218 live studies being conducted; many of these taking place in London and Nova Scotia."
How is IDegLira being used to improve patient outcomes?
"IDegLira is a medication most commonly used to treat cardiovascular disease, but it can also be given to patients with type 1 diabetest cardiovascular disease, but it can also be given to patients with type 1 diabetes mellitus as well as those looking to improve their liraglutide levels through exercise."
How do I sign up for this experiment?
"This clinical study is accepting 159 participants that have type 2 diabetes mellitus and are between 30 and 80 years old."
What is the IDegLira drug's official medical standing?
"IDegLira received a safety score of 3 because there is both efficacy data and multiple rounds of supportive safety data from Phase 3 trials."
In how many different geographical areas is this trial being run?
"Currently, this trial is open to enrolment at 8 clinics. These locations are situated in London, Ottawa and Hamilton as well as 8 other cities. If you want to make the process of enrolling simpler, choose the clinic nearest to your home."
How many people are taking part in this experiment at most?
"Unfortunately, this study has already ended recruitment and is no longer admitting patients. The trial was initially posted on April 23rd, 2019 but was most recently updated on October 19th, 2020. For those still searching for studies, there are currently 1508 trials actively admitting patients with type 2 diabetes mellitus and 218 studies for IDegLira actively searching for patients."
Can new participants still join this experiment?
"This study is not enrolling new patients at this time, however that may change in the future as the clinical trial was most recently updated on 10/19/2022. There are 1726 other trials that you might be eligible for if you meet their inclusion criteria."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends